Needham & Company Reiterates a 'Buy' on Cantel Medical (CMN); Continues To Top Expectations
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Cantel Medical (NYSE: CMN) price target of $28.00 (from $26.00).
Analyst, Dalton ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Dalton ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
